title: Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression.
abstract: Angiotensin-II (Ang-II) from extracardiac sources and intracardiac synthesis regulates cardiac homeostasis, with mitogenic and growth-promoting effects largely due to altered gene expression. Here, we assessed the possibility that angiotensin-1 (AT1R) or angiotensin-2 (AT2R) receptors on the nuclear envelope mediate effects on cardiomyocyte gene expression. Immunoblots of nucleus-enriched fractions from isolated cardiomyocytes indicated the presence of AT1R and AT2R proteins that copurified with the nuclear membrane marker nucleoporin-62 and histone-3, but not markers of plasma (calpactin-I), Golgi (GRP-78), or endoplasmic reticulum (GM130) membranes. Confocal microscopy revealed AT1R and AT2R proteins on nuclear membranes. Microinjected Ang-II preferentially bound to nuclear sites of isolated cardiomyocytes. AT1R and AT2R ligands enhanced de novo RNA synthesis in isolated cardiomyocyte nuclei incubated with [alpha-(32)P]UTP (e.g. 36.0 +/- 6.0 cpm/ng of DNA control versus 246.4 +/- 15.4 cpm/ng of DNA Ang-II, 390.1 +/- 15.5 cpm/ng of DNA L-162313 (AT1), 180.9 +/- 7.2 cpm/ng of DNA CGP42112A (AT2), p < 0.001). Ang-II application to cardiomyocyte nuclei enhanced NFkappaB mRNA expression, a response that was suppressed by co-administration of AT1R (valsartan) and/or AT2R (PD123177) blockers. Dose-response experiments with Ang-II applied to purified cardiomyocyte nuclei versus intact cardiomyocytes showed greater increases in NFkappaB mRNA levels at saturating concentrations with approximately 2-fold greater affinity upon nuclear application, suggesting preferential nuclear signaling. AT1R, but not AT2R, stimulation increased [Ca(2+)] in isolated cardiomyocyte nuclei. Inositol 1,4,5-trisphosphate receptor blockade by 2-aminoethoxydiphenyl borate prevented AT1R-mediated Ca(2+) release and attenuated AT1R-mediated transcription initiation responses. We conclude that cardiomyocyte nuclear membranes possess angiotensin receptors that couple to nuclear signaling pathways and regulate transcription. Signaling within the nuclear envelope (e.g. from intracellularly synthesized Ang-II) may play a role in Ang-II-mediated changes in cardiac gene expression, with potentially important mechanistic and therapeutic implications.
authors.affiliation: Department of Medicine, Montreal Heart Institute, H1T 1C8 Montreal, Quebec, Canada.
authors.forename: Artavazd
authors.initials: A
authors.lastname: Tadevosyan
authors.forename: Ange
authors.initials: A
authors.lastname: Maguy
authors.forename: Louis R
authors.initials: LR
authors.lastname: Villeneuve
authors.forename: Judith
authors.initials: J
authors.lastname: Babin
authors.forename: Arnaud
authors.initials: A
authors.lastname: Bonnefoy
authors.forename: Bruce G
authors.initials: BG
authors.lastname: Allen
authors.forename: Stanley
authors.initials: S
authors.lastname: Nattel
mesh_terms: D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D002467:Cell Nucleus / Q000378:metabolism*; D002469:Cell Separation; D005110:Extracellular Space / Q000378:metabolism; D005786:Gene Expression Regulation; D053496:Inositol 1,4,5-Trisphosphate Receptors / Q000378:metabolism; D042541:Intracellular Space / Q000378:metabolism; D008297:Male; D008845:Microinjections; D009206:Myocardium / Q000166:cytology / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000378:metabolism*; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism; D021381:Protein Transport; D051381:Rats; D017208:Rats, Wistar; D044140:Receptor, Angiotensin, Type 1 / Q000235:genetics / Q000378:metabolism*; D044139:Receptor, Angiotensin, Type 2 / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D013347:Subcellular Fractions / Q000378:metabolism; D014158:Transcription, Genetic
chemical_list: D053496:Inositol 1,4,5-Trisphosphate Receptors; D016328:NF-kappa B; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D000804:Angiotensin II
references.citation: Diabetes. 2008 Dec;57(12):3297-306
references.pmid: 18829990
references.citation: Cardiovasc Res. 2006 Jul 1;71(1):69-78
references.pmid: 16631628
references.citation: J Physiol. 2007 Oct 15;584(Pt 2):601-11
references.pmid: 17761776
references.citation: Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12457-62
references.pmid: 18711143
references.citation: Tissue Cell. 1994 Dec;26(6):943-55
references.pmid: 7886680
references.citation: Endocrinology. 1992 Jun;130(6):3641-9
references.pmid: 1597161
references.citation: Endocr Rev. 2000 Feb;21(1):90-113
references.pmid: 10696571
references.citation: Cell. 1993 Dec 3;75(5):977-84
references.pmid: 8252633
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H939-48
references.pmid: 17483239
references.citation: Circ Res. 1996 Oct;79(4):765-72
references.pmid: 8831500
references.citation: Immunol Cell Biol. 2000 Aug;78(4):387-94
references.pmid: 10947863
references.citation: Science. 1971 Jun 11;172(3988):1138-9
references.pmid: 4324923
references.citation: Hypertension. 2006 May;47(5):894-900
references.pmid: 16585419
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15792-7
references.pmid: 9861049
references.citation: Hypertension. 2007 Jun;49(6):1196-201
references.pmid: 17452509
references.citation: J Biol Chem. 2003 Aug 1;278(31):29153-63
references.pmid: 12756260
references.citation: J Clin Pharmacol. 2008 Mar;48(3):344-50
references.pmid: 18223145
references.citation: J Cell Sci. 2004 Jul 1;117(Pt 15):3087-94
references.pmid: 15226390
references.citation: Endocrinology. 1992 Jul;131(1):374-80
references.pmid: 1612017
references.citation: Circ Res. 2008 Oct 24;103(9):992-1000
references.pmid: 18802028
references.citation: Br J Pharmacol. 2001 Apr;132(7):1590-6
references.pmid: 11264254
references.citation: Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1900-7
references.pmid: 17586619
references.citation: J Hypertens. 2007 Aug;25(8):1643-9
references.pmid: 17620961
references.citation: Circ Res. 2002 May 31;90(10):1135-41
references.pmid: 12039805
references.citation: Nat Clin Pract Cardiovasc Med. 2007 Oct;4(10):549-57
references.pmid: 17893683
references.citation: N Engl J Med. 1997 Apr 10;336(15):1066-71
references.pmid: 9091804
references.citation: Hypertension. 1998 Dec;32(6):976-82
references.pmid: 9856960
references.citation: Biol Res. 2006;39(3):541-53
references.pmid: 17106585
references.citation: Cell. 1998 Jan 9;92(1):17-23
references.pmid: 9489696
references.citation: Brain Res Mol Brain Res. 1996 Jun;38(2):179-90
references.pmid: 8793106
references.citation: Regul Pept. 2006 Jan 15;133(1-3):10-2
references.pmid: 16325280
references.citation: Proc Soc Exp Biol Med. 1991 Mar;196(3):280-3
references.pmid: 1998005
references.citation: Nature. 2000 Sep 7;407(6800):94-8
references.pmid: 10993080
references.citation: Lancet. 2002 Mar 23;359(9311):995-1003
references.pmid: 11937178
references.citation: Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17818-23
references.pmid: 19008357
references.citation: J Biol Chem. 2008 Oct 10;283(41):27859-27870
references.pmid: 18632662
references.citation: J Hypertens. 2003 Nov;21(11):2175-82
references.pmid: 14597862
references.citation: EMBO J. 1999 Apr 1;18(7):1723-9
references.pmid: 10202136
references.citation: Br J Cancer. 2004 Mar 8;90(5):1059-68
references.pmid: 14997208
references.citation: J Mol Med (Berl). 2002 Jun;80(6):359-66
references.pmid: 12072911
references.citation: Regul Pept. 2004 Aug 15;120(1-3):5-13
references.pmid: 15177915
references.citation: Am J Physiol Cell Physiol. 2008 Apr;294(4):C1034-45
references.pmid: 18256274
references.citation: J Am Coll Cardiol. 2005 Mar 1;45(5):705-11
references.pmid: 15734614